Division of Global HIV & TB, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Division of Global HIV & TB, US Centers for Disease Control and Prevention, CDC-Kenya, Nairobi, Kenya.
J Adolesc Health. 2019 Feb;64(2):242-249. doi: 10.1016/j.jadohealth.2018.08.013. Epub 2018 Oct 25.
PURPOSE: Informing adolescents of their own HIV infection is critical as the number of adolescents living with HIV increases. We assessed the association between HIV disclosure and retention in care and mortality among adolescents aged 10-14 years in Kenya's national program. METHODS: We abstracted routinely collected patient-level data for adolescents enrolled into HIV care in 50 health facilities from November 1, 2004, through March 31, 2010. We defined disclosure as any documentation that the adolescent had been fully or partially made aware of his or her HIV status. We compared weighted proportions for categorical variables using χ2 and weighted logistic regression to identify predictors of HIV disclosure; we estimated the probability of LTFU using Kaplan-Meier methods and dying using Cox regression-based test for equality of survival curves. RESULTS: Of the 710 adolescents aged 10-14 years analyzed; 51.3% had severe immunosuppression, 60.3% were in WHO stage 3 or 4, and 36.6% were aware of their HIV status. Adolescents with HIV-infected parents, histories of opportunistic infections (OIs), and enrolled in support groups were more likely to be disclosed to. At 36 months, disclosure was associated with lower mortality [1.5% (95% CI .6%-4.1%) versus 5.4% (95% CI 3.6.6%-8.0%, p < .001)] and lower LTFU [6.2% (95% CI 3.0%-12.6%) versus 33.9% (95% CI 27.3%-41.1%) p < .001]. CONCLUSIONS: Only one third of HIV-infected Kenyan adolescents in treatment programs had been told they were infected, and knowing their HIV status was associated with reduced LTFU and mortality. The disclosure process should be systematically encouraged and organized for HIV-infected adolescents.
目的:随着感染艾滋病毒的青少年人数不断增加,告知青少年自身感染艾滋病毒的情况至关重要。我们评估了肯尼亚国家项目中,10-14 岁青少年中艾滋病毒披露与治疗保留和死亡率之间的关联。
方法:我们从 2004 年 11 月 1 日至 2010 年 3 月 31 日,从 50 个卫生机构中抽取了接受艾滋病毒护理的青少年的常规收集患者数据。我们将披露定义为任何记录表明青少年已充分或部分了解其艾滋病毒状况。我们使用 χ2 和加权逻辑回归比较了分类变量的加权比例,以确定艾滋病毒披露的预测因素;我们使用 Kaplan-Meier 方法估计 LTFU 的概率,并使用 Cox 回归基于生存曲线相等性的检验来估计死亡概率。
结果:在分析的 710 名 10-14 岁的青少年中,51.3%有严重免疫抑制,60.3%处于世卫组织第 3 或 4 期,36.6%知道自己的艾滋病毒状况。有感染艾滋病毒的父母、机会性感染史和参加支持小组的青少年更有可能被披露。在 36 个月时,披露与较低的死亡率相关[1.5%(95%CI.6%-4.1%)与 5.4%(95%CI 3.6.6%-8.0%,p<.001)]和较低的 LTFU[6.2%(95%CI 3.0%-12.6%)与 33.9%(95%CI 27.3%-41.1%,p<.001)]。
结论:在治疗项目中,只有三分之一的感染艾滋病毒的肯尼亚青少年被告知他们已被感染,而了解其艾滋病毒状况与降低 LTFU 和死亡率有关。应系统地鼓励和组织艾滋病毒感染青少年进行披露。
J Adolesc Health. 2018-10-25
BMC Public Health. 2018-5-30
Rwanda J Med Health Sci. 2024-3-31
PLOS Glob Public Health. 2022-2-22
HIV AIDS (Auckl). 2022-12-21
J Adolesc Health. 2015-1
AIDS Patient Care STDS. 2014-10
J Adolesc Health. 2014-10